Top news of the week: 23.06.2020.
#CoronaVirus #biotechnology #CoronaOutbreak #COVID19 #CoronaPandemic #biospace #lifesciences #pharmaceuticals
Companies And Industries
California biotech @PoseidaThera has become the latest biotech to hit the IPO trial after a string of launches last week, seeking $115 million in funding for CAR-T projects https://t.co/S0ftbkjgPz
OpenPoseida Therapeutics aims for $115m stock market launch to fund CAR-T R&D
California biotech Poseida Therapeutics has become the latest biotech to hit the IPO trial after a string of launches last week, seeking $115 million in funding for projects including a ...
Biopharma Update on the Novel Coronavirus: June 17
#biospace #lifesciences #biotechnology #pharmaceuticals
#CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic
https://t.co/OnwVgShJY2
OpenBiopharma Update on the Novel Coronavirus: June 17
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 17, 2020.
The Implications of Workplace COVID-19 Testing for Biotech, Pharma and Others
#biospace #lifesciences #biotechnology #pharmaceuticals
#CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic
https://t.co/Rea1B1RbIW
OpenThe Implications of Workplace COVID-19 Testing for Biotech, Pharma and Others
Numerous biopharma companies are testing or working to develop drugs and vaccines. But what is a bit unusual is the number of staffers at biotech and pharma companies and health care ...
Biopharma Update on the Novel #Coronavirus: June 19 https://t.co/skGxjRQgpV https://t.co/XkhoJzYYjZ
OpenBiopharma Update on the Novel Coronavirus: June 19
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 19, 2020.
Biopharma Update on the Novel Coronavirus: June 22
#biospace #lifesciences #biotechnology #pharmaceuticals
#CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic
https://t.co/NqPj5QkBkV
OpenBiopharma Update on the Novel Coronavirus: June 22
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 22, 2020.
CNBG reports 100% seroconversion rate for COVID-19 vaccine candidate
BEIJING – Chinese state-backed vaccine developer China National Biotec Group (CNBG), of Beijing, said on Tuesday night that its inactivated COVID-19 vaccine candidate produced a ...
Emergent plots $75M expansion to produce viral vectors for expanding gene therapy business https://t.co/eTNOQ0SPER
OpenGET THE NEWSLETTER
Maryland-based Emergent BioSolutions has worked its way to the front lines of the COVID-19 vaccine manufacturing field with a suite of deals to produce U.S. supply. But Emergent has more on ...
We’re bringing forward an antibody we’ve developed based on inputs from CSL. It’s an improved version of what CSL had and we’re working toward an IND for 2021, CEO Barrett said https://t.co/pqvJDTuESa
OpenLassen Therapeutics uncloaks with $31M and anti-IL-11 antibody
There’s a new antibody player on the block—Lassen Therapeutics is coming out of the shadows with $31 million from Frazier Healthcare Partners, Alta Venture and Longwood Fund and a mission ...